PPA
NXTC icon

Parametric Portfolio Associates’s NextCure NXTC Stock Holding History

Parametric Portfolio Associates’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,261
Closed -$151K – 3590
2021
Q1 		$151K Sell
1,261
-1,893
-60% -$274K ﹤0.01% 3926
2020
Q4 		$412K Buy
3,154
+1,282
+68% +$166K ﹤0.01% 3462
2020
Q3 		$198K Buy
1,872
+602
+47% +$74K ﹤0.01% 3657
2020
Q2 		$327K Buy
1,270
+53
+4% +$20.2K ﹤0.01% 3443
2020
Q1 		$542K Buy
1,217
+72
+6% +$38.5K ﹤0.01% 3122
2019
Q4 		$774K Buy
+1,145
New +$574K ﹤0.01% 3185

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Parametric Portfolio Associates's NXTC Position: Q2 2021 in Review

Parametric Portfolio Associates sold out of NextCure (NXTC) in Q2 2021, closing a stake of 1,261 shares — an estimated $151K sold.

Parametric Portfolio Associates first reported a position in NXTC in Q4 2019 and held it in 6 quarters. The position peaked at $774K in Q4 2019. 78 funds tracked by Wall St. Rank hold NXTC as of Q2 2021.

  • Parametric Portfolio Associates reported no remaining NextCure position as of Q2 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 1,261 NextCure shares in Q2 2021, an estimated $151K.
  • Parametric Portfolio Associates first reported a position in NextCure in Q4 2019 and held it in 6 quarters.
  • Parametric Portfolio Associates's NextCure position peaked at $774K in Q4 2019.
  • 78 funds tracked by Wall St. Rank held NextCure as of Q2 2021.

Based on Parametric Portfolio Associates's 13F filing for Q2 2021, filed 13 Aug 2021.